Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Neoplasms × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 2 Visceral Pain 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Neuralgia 1 Neoplasms 1 Lymphoma 1 Leiomyoma 1 Earache 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Gemcitabine 86 130-nm albumin-bound paclitaxel 30 Oxaliplatin 27 Fluorouracil 24 Capecitabine 24 Leucovorin 19 Albumin-Bound Paclitaxel 19 Irinotecan 17 Erlotinib Hydrochloride 12 Cyclophosphamide 11 Bevacizumab 10 pembrolizumab 9 Radiotherapy 9 Radiosurgery 9 Nivolumab 9 Surgical Procedures, Operative 8 avelumab 6 Docetaxel 6 Cisplatin 6 ruxolitinib 5 folfirinox 5 Taxes 5 Paclitaxel 5 Everolimus 5 Cetuximab 5 ALT-803 5 spartalizumab 4 Specimen Handling 4 Radiotherapy, Intensity-Modulated 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01768988 2017-10-06

PANPAIN/1

Parc de Salut Mar

Phase 4 Terminated

Gastrointestinal

Pancreatic Neoplasms, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡